Found: 28
Select item for more details and to access through your institution.
Corrigendum.
- Published in:
- Diabetes, Obesity & Metabolism, 2022, v. 24, n. 7, p. 1406, doi. 10.1111/dom.14727
- Publication type:
- Article
Corrigendum.
- Published in:
- Diabetes, Obesity & Metabolism, 2022, v. 24, n. 7, p. 1407, doi. 10.1111/dom.14728
- Publication type:
- Article
Comparison of MiniMed 780G system performance in users aged younger and older than 15 years: Evidence from 12 870 real‐world users.
- Published in:
- Diabetes, Obesity & Metabolism, 2022, v. 24, n. 7, p. 1370, doi. 10.1111/dom.14714
- By:
- Publication type:
- Article
Efficacy and safety of cotadutide, a dual glucagon‐like peptide‐1 and glucagon receptor agonist, in a randomized phase 2a study of patients with type 2 diabetes and chronic kidney disease.
- Published in:
- Diabetes, Obesity & Metabolism, 2022, v. 24, n. 7, p. 1360, doi. 10.1111/dom.14712
- By:
- Publication type:
- Article
Types of diet, obesity, and incident type 2 diabetes: Findings from the UK Biobank prospective cohort study.
- Published in:
- Diabetes, Obesity & Metabolism, 2022, v. 24, n. 7, p. 1351, doi. 10.1111/dom.14711
- By:
- Publication type:
- Article
Efficacy and safety of oral semaglutide by subgroups of patient characteristics in the PIONEER phase 3 programme.
- Published in:
- Diabetes, Obesity & Metabolism, 2022, v. 24, n. 7, p. 1338, doi. 10.1111/dom.14710
- By:
- Publication type:
- Article
Cost‐effectiveness of sodium‐glucose cotransporter‐2 inhibitors versus dipeptidyl peptidase‐4 inhibitors among patients with type 2 diabetes with and without established cardiovascular diseases: A model‐based simulation analysis using 10‐year real‐world data and targeted literature review
- Published in:
- Diabetes, Obesity & Metabolism, 2022, v. 24, n. 7, p. 1328, doi. 10.1111/dom.14708
- By:
- Publication type:
- Article
Cardiovascular efficacy of liraglutide and semaglutide in individuals with diabetes and peripheral artery disease.
- Published in:
- Diabetes, Obesity & Metabolism, 2022, v. 24, n. 7, p. 1288, doi. 10.1111/dom.14700
- By:
- Publication type:
- Article
Efficacy, safety, tolerability, and noninferiority phase 3 study of glucagon as a ready‐to‐use room temperature liquid stable formulation versus a lyophilised formulation for the biochemical recovery and symptomatic relief of insulin‐induced severe hypoglycaemia in adults with type 1 diabetes
- Published in:
- Diabetes, Obesity & Metabolism, 2022, v. 24, n. 7, p. 1394, doi. 10.1111/dom.14699
- By:
- Publication type:
- Article
Healthcare costs and hospitalizations in US patients with type 2 diabetes and cardiovascular disease: A retrospective database study (OFFSET).
- Published in:
- Diabetes, Obesity & Metabolism, 2022, v. 24, n. 7, p. 1300, doi. 10.1111/dom.14703
- By:
- Publication type:
- Article
Association between antidiabetic drug use and the risk of COVID‐19 hospitalization in the INSIGHT Clinical Research Network in New York City.
- Published in:
- Diabetes, Obesity & Metabolism, 2022, v. 24, n. 7, p. 1402, doi. 10.1111/dom.14704
- By:
- Publication type:
- Article
Injectable semaglutide and reductions in HbA1c and weight in the real world in people switched from alternative glucagon‐like peptide‐1 receptor agonists.
- Published in:
- Diabetes, Obesity & Metabolism, 2022, v. 24, n. 7, p. 1398, doi. 10.1111/dom.14701
- By:
- Publication type:
- Article
In‐home use of a hybrid closed loop achieves time‐in‐range targets in preschoolers and school children: Results from a randomized, controlled, crossover trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2022, v. 24, n. 7, p. 1319, doi. 10.1111/dom.14706
- By:
- Publication type:
- Article
Early and ongoing stable glycaemic control is associated with a reduction in major adverse cardiovascular events in people with type 2 diabetes: A primary care cohort study.
- Published in:
- Diabetes, Obesity & Metabolism, 2022, v. 24, n. 7, p. 1310, doi. 10.1111/dom.14705
- By:
- Publication type:
- Article
Cost of healthcare utilization associated with incident cardiovascular and renal disease in individuals with type 2 diabetes: A multinational, observational study across 12 countries.
- Published in:
- Diabetes, Obesity & Metabolism, 2022, v. 24, n. 7, p. 1277, doi. 10.1111/dom.14698
- By:
- Publication type:
- Article
Modifying chronic kidney disease progression with the mineralocorticoid receptor antagonist finerenone in patients with type 2 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2022, v. 24, n. 7, p. 1197, doi. 10.1111/dom.14696
- By:
- Publication type:
- Article
Previously unrecognized risk factors for severe hypoglycaemia requiring emergency medical care in insulin‐treated type 2 diabetes: Results from a real‐world nested case‐control study.
- Published in:
- Diabetes, Obesity & Metabolism, 2022, v. 24, n. 7, p. 1235, doi. 10.1111/dom.14690
- By:
- Publication type:
- Article
Empagliflozin and incidence of events consistent with acute kidney injury: Pooled safety analysis in more than 15 000 individuals.
- Published in:
- Diabetes, Obesity & Metabolism, 2022, v. 24, n. 7, p. 1390, doi. 10.1111/dom.14694
- By:
- Publication type:
- Article
Sodium‐glucose co‐transporter‐2 inhibitors in patients with type 2 diabetes: Barriers and solutions for improving uptake in routine clinical practice.
- Published in:
- Diabetes, Obesity & Metabolism, 2022, v. 24, n. 7, p. 1187, doi. 10.1111/dom.14684
- By:
- Publication type:
- Article
The benefit of dexamethasone in patients with COVID‐19 infection is preserved in patients with diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2022, v. 24, n. 7, p. 1385, doi. 10.1111/dom.14692
- By:
- Publication type:
- Article
Cardiorenal outcomes with ertugliflozin assessed according to baseline glucose‐lowering agent: An analysis from VERTIS CV.
- Published in:
- Diabetes, Obesity & Metabolism, 2022, v. 24, n. 7, p. 1245, doi. 10.1111/dom.14691
- By:
- Publication type:
- Article
A low n‐6 to n‐3 polyunsaturated fatty acid ratio diet improves hyperinsulinaemia by restoring insulin clearance in obese youth.
- Published in:
- Diabetes, Obesity & Metabolism, 2022, v. 24, n. 7, p. 1267, doi. 10.1111/dom.14695
- By:
- Publication type:
- Article
Integrated metagenomics and metabolomics analysis illustrates the systemic impact of the gut microbiota on host metabolism after bariatric surgery.
- Published in:
- Diabetes, Obesity & Metabolism, 2022, v. 24, n. 7, p. 1224, doi. 10.1111/dom.14689
- By:
- Publication type:
- Article
The alpha‐7 nicotinic acetylcholine receptor agonist GTS‐21 engages the glucagon‐like peptide‐1 incretin hormone axis to lower levels of blood glucose in db/db mice.
- Published in:
- Diabetes, Obesity & Metabolism, 2022, v. 24, n. 7, p. 1255, doi. 10.1111/dom.14693
- By:
- Publication type:
- Article
Changes over time in the cardiovascular risk profile of type 2 diabetes from 2007 to 2020: A community‐based study.
- Published in:
- Diabetes, Obesity & Metabolism, 2022, v. 24, n. 7, p. 1216, doi. 10.1111/dom.14686
- By:
- Publication type:
- Article
Glucagon‐like peptide‐1 receptor agonist prescribing patterns in adolescents with type 2 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2022, v. 24, n. 7, p. 1380, doi. 10.1111/dom.14681
- By:
- Publication type:
- Article
Alliance of Randomized Trials of Medicine vs Metabolic Surgery in Type 2 Diabetes (ARMMS‐T2D): Study rationale, design, and methods.
- Published in:
- Diabetes, Obesity & Metabolism, 2022, v. 24, n. 7, p. 1206, doi. 10.1111/dom.14680
- By:
- Publication type:
- Article
Diabetes, Obesity and Metabolism.
- Published in:
- Diabetes, Obesity & Metabolism, 2022, v. 24, n. 7, p. 1185, doi. 10.1111/dom.14431
- Publication type:
- Article